A detailed history of Virtus Investment Advisers, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 42,730 shares of DVAX stock, worth $444,392. This represents 0.15% of its overall portfolio holdings.

Number of Shares
42,730
Previous 27,636 54.62%
Holding current value
$444,392
Previous $358,000 18.16%
% of portfolio
0.15%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$9.4 - $12.87 $141,883 - $194,259
15,094 Added 54.62%
42,730 $423,000
Q1 2025

May 14, 2025

BUY
$12.39 - $14.4 $342,410 - $397,958
27,636 New
27,636 $358,000
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $100,759 - $176,963
10,147 New
10,147 $106,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.32B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Virtus Investment Advisers, Inc. Portfolio

Follow Virtus Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.